Dachaigh › Ailseachadh nan Sgamhan › Michigan › Detroit
Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Detroit, MI
Tha 20 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann agus timcheall air Detroit (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
A’ fastadhÌre 3
- Henry Ford Health Saint John Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
A’ fastadhÌre 3
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A’ fastadhÌre 3
- Karmanos Cancer Institute, Detroit
- Henry Ford Health, Detroit
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A’ fastadhÌre 2/3
- Local Institution - 0405, Detroit
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A’ fastadhÌre 1
- Karmanos Cancer Institiute, Detroit
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A’ fastadhÌre 1
- Henry Ford Cancer - Detroit, Detroit
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
A’ fastadhÌre 3
- Henry Ford Cancer Institute, Detroit
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Wayne State University/Karmanos Cancer Institute, Detroit
- Henry Ford Hospital, Detroit
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
A’ fastadhÌre 3
- Wayne State University/Karmanos Cancer Institute, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- Karmanos Cancer Institute, Detroit
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
A’ fastadhÌre 1/2
- Henry Ford Cancer Institute, Detroit
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
A’ fastadhÌre 2
- Henry Ford Cancer- Detroit, Detroit
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
A’ fastadhÌre 1/2
- Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
A’ fastadhÌre 2
- Karmanos Cancer Institute, Detroit
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Henry Ford Hospital, Detroit
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
A’ fastadhÌre 1/2
- Karmanos Cancer Institute, Detroit
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
A’ fastadhÌre 1/2
- Henry Ford Health, Detroit
Sgrùdaidhean Ailseachadh nan Sgamhan ann am bailtean eile
- Houston, TX78 sgrùdaidhean
- Boston, MA62 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Los Angeles, CA45 sgrùdaidhean
- Arlington, VA41 sgrùdaidhean
- Washington, DC41 sgrùdaidhean
- Chicago, IL41 sgrùdaidhean
- Baltimore, MD40 sgrùdaidhean
- Nashville, TN40 sgrùdaidhean
- St. Louis, MO39 sgrùdaidhean
- Columbus, OH37 sgrùdaidhean
- Philadelphia, PA36 sgrùdaidhean
Sgrùdaidhean eile ann an Detroit
- Aillse Sgamhain Neo-chealla-beag44 sgrùdaidhean
- Aillse a' bhroilleach33 sgrùdaidhean
- Aillse (gach seòrsa)29 sgrùdaidhean
- Aillse colorectal26 sgrùdaidhean
- Cancer Ovarian26 sgrùdaidhean
- Ailse metastatach24 sgrùdaidhean
- Aillse Prostata22 sgrùdaidhean
- Ailse Endometrial21 sgrùdaidhean
- Myeloma iomaill19 sgrùdaidhean
- Aillse a' Bhroinn16 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil15 sgrùdaidhean
- Leukemia myeloid geur14 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.